AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Purchase
+$1,560,000
+35.3%
Shares
Shares Volume: 1,500,000 Shares
Average Share Price: $1.04
INSIDER
Leonard Braden Michael
10% Owner
reported on Aug 14 2024
traded on Aug 14 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 5,749,432 |
| PURCHASES/SALES 1Y | 1 / 0 |
| P/S VALUE RATIO | n/a |
| AVERAGE PURCHASE VALUE | $1,560,000 |
| INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 1 / 1 |
| PURCHASES/SALES 1Y | 2 / 37 |
| P/S VALUE RATIO | 1.252 |
| AVERAGE PURCHASE VALUE | $8,780,001 |
| COMPANY PREVIOUS TRADES |